Sorry, you need to enable JavaScript to visit this website.

PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)) Dosage Forms, Composition And Packaging

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Dosage Forms, Composition And Packaging

Each 0.5 mL dose of the vaccine is formulated to contain approximately 2.2 µg of each saccharide for Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F and 23F, 4.4 µg of saccharide for serotype 6B, 34 µg CRM197 carrier protein, 4.25 mg sodium chloride, 100 µg polysorbate 80, 295 µg succinic acid and 125 µg aluminum as aluminum phosphate adjuvant.

The vaccine is a white suspension for injection and provided in a single-dose, pre-filled syringe (0.5 mL). Pack sizes of 1 and 10, without needles. The tip cap and rubber plunger of the pre-filled syringe do not contain latex.


Control #: 219617
August 8, 2019

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111